Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
1(14%)
Results Posted
100%(1 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_4
1
14%
Ph phase_3
1
14%
Ph phase_2
3
43%
Ph early_phase_1
2
29%

Phase Distribution

2

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

16.7%

1 of 6 finished

Non-Completion Rate

83.3%

5 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(1)
Terminated(5)

Detailed Status

Withdrawn3
Terminated2
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (28.6%)
Phase 23 (42.9%)
Phase 31 (14.3%)
Phase 41 (14.3%)

Trials by Status

terminated229%
withdrawn343%
recruiting114%
completed114%

Recent Activity

1 active trials
Showing 5 of 7
recruitingearly_phase_1

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder

NCT03748446
withdrawnearly_phase_1

S-Nitrosylation Therapy of COVID-19

NCT04528771
withdrawnphase_2

iNOPulse for COVID-19

NCT04398290
withdrawnphase_4

Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

NCT01891500
terminatedphase_2

The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients

NCT00782652
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03748446Early Phase 1

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder

Recruiting
NCT04528771Early Phase 1

S-Nitrosylation Therapy of COVID-19

Withdrawn
NCT04398290Phase 2

iNOPulse for COVID-19

Withdrawn
NCT01891500Phase 4

Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

Withdrawn
NCT00782652Phase 2

The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients

Terminated
NCT00041561Phase 3

Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

Terminated
NCT00582010Phase 2

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7